Part 16: Evaluation and Management of Neurologic Disorders

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement, not replace, the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

So picture this.

A 45 -year -old woman walks into your clinic and she just looks terrified.

Oh, wow.

Okay.

Yeah.

And you immediately see why, right?

The entire right side of her face is drooping.

She's slurring her words.

She can't close her right eye and her mouth is just pulled downward.

That is a classic, terrifying presentation.

It really is.

Your heart rate immediately spikes.

I mean, if you are a medical student or a new clinician, your brain starts flashing this bright red warning light.

You're thinking, stroke,

massive central nervous system event.

Right, the ticking clock.

Exactly.

Yeah.

But is it?

Because the difference between activating an emergency stroke protocol and just sending her home with a prescription for steroids and eye drops comes down to a single, incredibly simple instruction.

Yeah.

The physical exam is everything here.

You literally just look her in the eye and say, please raise your eyebrows.

And what happens next completely alters her trajectory of care.

It's honestly one of the most elegant, high -stakes moments in physical medicine.

I mean, it perfectly illustrates the razor's edge we walk in primary care neurology.

It really does.

So welcome to this deep dive.

Today we are speaking directly to you, the college student, the future clinician,

the medical resident who is encountering complex primary care neurology for the very first time.

Because it can be overwhelming.

Oh, totally.

Good.

We're diving into the diagnostic muddy waters of 14 critical neurologic conditions, and this is all drawn straight from the latest interprofessional collaborative practice guidelines.

And we aren't just going to read a list of what these diseases are.

No, definitely not.

We are going to tear down the engine.

We'll show you exactly how they work, why they present the way they do, and how you coordinate a massive health care team to manage them.

Because the reality is you're never just memorizing a textbook.

You're learning how to be the central node in a vast network of care.

You really are the ultimate diagnostician.

I like to think of primary care like being an air traffic controller.

Oh, that's a great analogy.

Right.

You're sitting in the tower looking at a radar screen.

A blip appears, and those are your patient's symptoms.

A dizzy spell, or a twitch in a muscle, or a sudden blinding headache.

Yeah, and you have to identify that incoming signal,

categorize the risk instantly, and then coordinate with a massive team.

Exactly.

Specialists, therapists, social workers.

You have to land that plane safely.

And just like air traffic control, the margin for error is slim.

You have to understand the underlying mechanism so you don't confuse a benign weather pattern with like a catastrophic engine failure.

So true.

Well, let's start with a condition that fundamentally alters the mechanics of human movement.

Imagine a patient who comes to you because they just keep tripping over their own feet.

Or maybe they've noticed a persistent visible twitching in their arms.

Yeah, exactly.

We're talking about amyotrophic lateral sclerosis, ALS, historically known as Lou Gehrig's disease.

ALS is a progressive and currently incurable neurodegenerative disorder.

It's a profoundly devastating diagnosis.

It really is.

To understand it, we kind of have to look at the wiring of the body.

ALS is unique because it attacks both upper motor neurons, which we call UMNs, and lower motor neurons, or LMNs.

Now, if you are listening to this right now and studying for your boards, please highlight this next point.

Yes, definitely.

Distinguishing upper from lower motor neuron signs is a guaranteed trick question on your exam.

I like to think of the nervous system's motor pathway as a car.

Okay, I like where this is going.

The upper motor neurons, which run from your brain down through your spinal cord, those are the brakes.

Right.

And the lower motor neurons, which run from your spinal cord out to your actual muscles, those are the engine.

That analogy works beautifully.

So if a disease knocks out the upper motor neurons, the brakes, what happens?

The car just goes wild, right?

Exactly.

The signal from the brain that normally modulates and dampens muscle activity is gone.

Everything becomes hyperactive.

So that's what we see on the physical exam.

Right.

You'll see hyperreflexia, meaning their reflexes are just exaggerated.

You'll see spasticity, where the muscles are tight and rigidly overreactive.

And the Babinski sign, right?

Yes.

A positive Babinski sign, where stroking the bottom of the foot causes the big toe to extend upward.

It's a primitive reflex that should be suppressed in adults.

So the brakes are out.

The system is running wild.

But what if a disease knocks out the lower motor neurons?

The engine.

Well, if you lose the engine, the electrical signal never reaches the muscle at all.

The muscle just sits there, completely unused.

Which leads to atrophy.

Profound muscle atrophy and flaccid weakness.

You also see fasciculations, which are those spontaneous visible twitches rippling under the skin as the dying nerve fires off randomly.

Wow.

So what makes ALS so distinct from other neuropathies?

It's that as the disease progresses, you see both sets of symptoms occurring simultaneously in the exact same patient.

Wait, really?

Both at once?

Yeah.

You might have a spastic hyperreflexic arm that is also actively atrophying and twitching.

That is just, it's brutal.

Yeah.

So why does this happen?

The literature notes that like 90 % of these cases are sporadic.

Meaning they strike without a clear family history, yeah.

Well, a small percentage are linked to specific genetic mutations.

I think it's the C9 or F72 or SOD1 genes.

That's correct.

But genetically linked or not, what is actually killing these neurons?

There are a few leading hypotheses, and they all kind of point to cellular toxicity.

The primary culprit appears to be glutamate excitotoxicity.

Glutamate.

That's an excitatory neurotransmitter, right?

It is.

It's an essential one in the brain.

And it's essentially the gas pedal for neuronal firing.

But in ALS, the theory is that glutamate isn't cleared away properly from the synaptic cleft.

So it just builds up.

Right.

It accumulates and essentially overstimulates the motor neurons until they literally die from exhaustion.

It just fries the circuit board.

Exactly.

It triggers this massive influx of calcium into the cell, which activates destructive enzymes.

Add to that mitochondrial defects and severe oxidative stress from free oxygen radicals.

And the motor neurons in the brainstem and spinal cord simply degenerate and die.

Now regarding clinical presentation, most patients start with limb weakness, right?

Like foot drop or trouble lifting their arms.

Yeah.

That's the most common initial presentation.

But about 25 % present with what's called bulbar onset.

Clinically, why is a bulbar onset a massive red flag for a much shorter survival duration?

So you suspect ALS in your clinic.

You look at the diagnostic protocols, and there is no simple blood test.

You can't just draw a vial, look for an ALS marker, and have your answer.

It is a diagnosis of exclusion.

You're basically playing detective.

You run a massive panel.

General chemistry, inflammatory markers like ESR, thyroid tests, B12 levels, and creatine kinase, which elevates when muscle breaks down.

You're just casting a wide net.

You have to.

You check liver function and perform serum protein electrophoresis to rule out autoimmune or perineoplastic syndromes.

You even analyze the cerebrospinal fluid.

You do MRIs of the brain and spine.

Not to find ALS, but to prove it isn't something else.

Right.

You are looking for a herniated disc pressing on a nerve, a tumor, or a stroke.

Once you've ruled all of that out, you rely on the gold standard diagnostic tool.

Which is?

Electromyography or EMG alongside nerve conduction studies.

OK.

This brings us to the formal diagnostic criteria, like the Awajishima criteria, which students will see heavily referenced in clinical guidelines.

Yes, that's a big one.

But I don't want to just memorize the name.

What is the core concept behind these criteria?

The core concept of Awajishima is balancing clinical observation with electrophysiological data.

To definitively diagnose ALS, you cannot just have weakness in one arm.

That's not enough.

No.

You need to document a progression of both upper and lower motor neuron dysfunction spreading across multiple distinct anatomical regions.

Like which regions?

The bulbar region, the cervical spine, the thoracic spine, and the lumbosacral region.

The EMG helps detect active denervation in muscles before the weakness is even clinically obvious to the naked eye.

It's like mapping the spread of a fire.

That's a great way to put it.

Let's talk about interprofessional management because this is where the primary care provider acts as that air traffic controller.

Pharmacologically, we're really just trying to slow this down.

We have rilazole.

Right.

Tying it back to our earlier pathophysiology, rilazole is an anti -glutamate drug.

It blocks the release of glutamate, attempting to stop that excitotoxicity.

It isn't a cure, though.

No, it isn't.

But it can extend ventilator -free survival by about two to three months.

It's a heavy drug, though.

You have to monitor liver enzymes closely and watch for neutropenia, which is a dangerous drop in white blood cells.

And then there's the newer addition, edurovone.

Edurovone acts as a free radical scavenger.

It specifically targets the oxidative stress hypothesis we mentioned.

It's an intensive intravenous infusion given on a cycle of 14 days on, followed by 14 days off.

But beyond those two, the pharmacology is entirely focused on quality of life, right?

Absolutely.

Like using SSRIs to manage pseudobulbar effect, which is a really stressing symptom where the patient has involuntary, uncontrollable episodes of laughing or crying that just don't match their actual mood.

Yes, and using anticholinergics to dry up celeria or severe drooling because they can no longer swallow their own saliva.

And this is where your collaborative care team is absolutely vital.

This is not a disease you manage alone in a 15 -minute primary care visit.

Not at all.

You need physical and occupational therapists to adapt the home environment as mobility fails.

And speech -language pathologists early on, too.

Right, not just for swallowing techniques, but for augmentative communication.

They assess the patient for computerized speech synthesizers or eye -tracking communication devices while the patient still has the energy to learn them.

And what about nutrition?

Because as that bulbar dysfunction progresses, eating becomes super dangerous.

You integrate dietitians and gastroenterology.

The clinical guideline is to proactively discuss placing a PEG tube,

a percutaneous endoscopic gastrostomy feeding tube, before it becomes an emergency.

Before they're completely malnourished.

Exactly.

You look at their forced vital capacity, or FVC.

You want to place that tube while their FVC is still greater than 50 % of their predicted value or as soon as they experience a 5 to 10 % loss of body weight.

And if you wait too long.

If you wait until they're in severe respiratory distress or highly malnourished, the surgical risk of placing the tube becomes astronomical.

It's just a profound systemic collapse.

It really is.

But in primary care,

you know, you don't just see chronic degeneration.

You also see acute terrifying nerve failures.

Which brings us perfectly back to the patient in our hook.

Yes, a sudden unilateral facial paralysis.

Let's unpack Bell -Polzi.

So Bell -Polzi is an acute unilateral weakness or complete paralysis of the facial nerve, which is cranial nerve seventh.

The onset is rapid, evolving in less than 72 hours.

Cranial nerve seventh is fascinating because it's a mixed nerve.

It has motor fibers controlling facial expression, sensory fibers for taste on the front of the tongue, and parasympathetic fibers for tear and saliva production.

It does a lot of work.

So what causes it to just suddenly shut down?

The leading hypothesis points to viral reactivation.

The theory is that a virus, most likely herpes simplex virus type 1, or perhaps varicella zoster, causes an initial infection and then goes dormant in the geniculate ganglion of the nerve.

Oh, like a sleeper agent.

Exactly.

And years later, some stressor like illness, immune suppression, or even extreme physical stress causes the virus to reactivate.

Now I have to ask,

if it's a virus attacking the nerve, why is the paralysis so complete and sudden?

Does the virus just like eat the nerve overnight?

It's not the virus directly destroying the nerve, it's the immune system's response to it.

The reactivation triggers massive inflammation.

Okay, inflammation.

Now cranial nerve 7th travels through the facial canal, which is a very narrow, rigid, bony tube inside the skull.

When the nerve gets inflamed, it swells.

But because it's trapped in a rigid bone canal, the swelling has nowhere to go.

Oh, so it compresses itself.

Exactly.

The swelling creates intense pressure, which cuts off the capillary blood supply to the nerve.

This is ischemia lack of oxygen causes the myelin sheath to break down, leading to demyelination and conduction block.

The electrical signal simply cannot get through the swollen suffocating nerve.

That structural reality explains everything.

So let's go back to our clinic room.

The patient is sitting there, half her face is paralyzed.

How do we know, without a shadow of a doubt, whether this is a swollen peripheral nerve in the facial canal or a massive stroke bleeding into her brain?

This is the clinical reasoning distinction every clinician must master.

It all comes down to the forehead.

You ask the patient to wrinkle their forehead or raise their eyebrows in surprise.

And what exactly are we looking for?

Bell palsy is a peripheral nerve lesion.

It knocks out the entire nerve trunk on that side.

Therefore, the paralysis involves the entire half of the face, including the forehead.

So they can't move it at all.

The patient will absolutely not be able to raise the eyebrow or wrinkle the forehead on the affected side.

It will be completely smooth.

But a stroke behaves differently.

Why?

Because a stroke is a central nervous system lesion occurring high up in the brain.

The motor cortex of the brain sends signals down to the facial nerve.

But there is a brilliant piece of evolutionary redundancy built into our wiring.

What kind of redundancy?

The upper motor neurons that control the lower half of the face crossover and only innervate the opposite side.

However, the upper motor neurons that control the upper face, the forehead, bifurcate.

They send signals to both sides of the forehead simultaneously.

Wait, really?

So the right hemisphere of the brain controls both the right A and D left sides of the forehead?

Yes.

So if a patient has a massive stroke in their left hemisphere,

the lower right side of their face will be paralyzed.

But because their healthy right hemisphere is still sending crossover signals to the forehead, they will still be able to wrinkle both sides of their forehead.

That is incredible.

So a stroke spares the forehead.

Bell palsy paralyzes the forehead.

That's the golden rule.

So if they can raise their eyebrows, you hit the panic button and call the stroke team.

If they can't, you diagnose Bell palsy.

Exactly.

If the forehead is spared, you must look for a central lesion, like a stroke or a brain tumor.

So once we confirm Bell palsy, what's the diagnostic workup?

Do we need an MRI right away to look at the nerve?

Emphatically, no.

Diagnosis is primarily clinical.

If it's a new, typical onset, routine labs and imaging are actively discouraged.

You are just wasting resources and exposing the patient to unnecessary testing.

Okay, but when do you break that rule?

Only if the presentation is atypical.

If both sides of the face are paralyzed, if the paralysis is slowly worsening over weeks instead of hours, or if there are other cranial nerve deficits like hearing loss or double vision.

Then you scan them.

Right.

Then you order an MRI with contrast.

You might also order Lyme disease titers if the patient lives in an endemic area or has a history of tick exposure, as Lyme can present as facial palsy.

Let's talk treatment.

If this is caused by a viral reactivation, my instinct says we hit them with heavy antivirals immediately.

You'd think so, but clinical trials tell a different story.

Antivirals alone, like valacyclovir, are statistically ineffective at changing the outcome.

Why is that?

Because as we discussed, the damage is from the inflammatory swelling, not the active viral replication.

Therefore, the absolute gold standard of treatment is a high dose taper of corticosteroids, like prednisone.

Because steroids crush the inflammation, reduce the swelling, and restore blood flow to the nerve in that tight bony canal.

Exactly.

And the window is tight.

You must start the steroids within 72 hours of symptom onset for maximum efficacy.

Do antivirals help at all?

Co -administering antivirals with the steroids provides only a very modest, roughly 7 % boost in recovery rates, mostly in severe cases.

But steroids are the star player.

But the pharmacology isn't even the most critical part of primary care management here, is it?

The biggest danger to this patient isn't the nerve damage, it's their eye.

This cannot be overstated.

Because the nerve is paralyzed, the patient loses their blink reflex.

They cannot close their eye.

This means the tear film evaporates, leaving the cornea completely exposed.

Which leads to exposure keratitis.

Yes, the cornea dries out, ulcerates, and they can suffer permanent blindness in that eye.

Wow.

So what's the care plan?

The interprofessional care plan must aggressively prioritize eye protection.

They need moisture chamber glasses during the day, they need lubricating drops every single hour, they need thick ocular ointment at bedtime, and you must teach them how to physically tape their eyelid completely shut with surgical tape before they go to sleep.

And if they have pain?

If they complain of any eye pain or you see redness, immediate referral to ophthalmology You also need to know that pregnancy dramatically alters the risk profile.

The incidence of bell palsy is three times higher during the third trimester of pregnancy in the first postpartum week.

It's believed to be linked to the increased fluid volume and generalized interstitial edema of pregnancy, which just adds to the compression inside that bony canal.

That makes perfect sense.

So in those cases, you must coordinate closely with their obstetrician.

Absolutely.

Now, we just talked about how to rule out a stroke.

But what happens when that forehead does wrinkle?

What happens when the blip on the radar is, in fact, a catastrophic cerebrovascular event?

Let's transition into our third topic,

strokes.

This is the fifth leading cause of death in the United States and a leading cause of long -term disability.

It is a massive public health crisis.

To understand stroke management, you have to split the pathology into two distinct categories, ischemic and hemorrhagic.

85 % of strokes are ischemic.

Meaning a blockage.

Yes.

A physical clot is blocking an artery's starving brain tissue of oxygen.

And ischemic strokes come in two flavors, right?

Thrombotic and embolic.

Right.

A thrombotic stroke happens when a plaque builds up in an artery inside the brain, usually due to long -term atherosclerosis, and a clot forms right there, shutting down the vessel.

And embolic.

An embolic stroke means the clot formed somewhere else very often in the heart due to atrial fibrillation, where the blood pools and coagulates and then that clot breaks loose, travels up the carotid artery, and wedges itself into a tiny cerebral vessel.

And the other 15 % of strokes.

Those are hemorrhagic.

A blood vessel literally bursts, bleeding directly into the brain tissue or the surrounding spaces.

This is most often caused by years of unmanaged hypertension severely weakening the arterial walls until they finally rupture.

We also have to address TIA's transient ischemic attacks.

We used to call these mini -strokes, but that terminology implies they aren't a big deal.

The text notes that TIAs proceed up to 10 % of all strokes.

A TIA is a temporary regional reduction in blood flow.

The patient gets stroke symptoms, slurred speech, weakness, but the clot devolves quickly on its own and the symptoms resolve completely within minutes to hours.

So it's not a mini -stroke?

No, it is not a mini -stroke.

It is a massive blaring siren warning you that a major stroke is imminent.

How do we risk stratify someone who just had a TIA in our clinic?

Do we send them home or to the ER?

You use the ABCD2 score.

It evaluates age, blood pressure, clinical features like unilateral weakness, duration of symptoms, and diabetes.

And a high score means what?

A high score means they have an extremely high risk of a full -blown stroke within the days and they require immediate, urgent neurological workup and management, usually hospital admission.

Okay, let's look closely at the initial diagnostics for a suspected acute stroke.

Time is brain.

Every minute a vessel is blocked, roughly 2 million neurons die.

It's terrifyingly fast.

The absolute first diagnostic test, non -ghostable, is a stat non -contrast head CT.

Why specifically non -contrast?

Why not use contrast diet to see the blood vessels better?

That is a phenomenal question.

It is entirely about ruling out a hemorrhagic stroke before you administer therapy.

The only way to save brain tissue and ischemic stroke is to give a thrombolytic, a clot -busting drug like TPA or tenecteplase.

But if you give a clot buster to a patient who is actively bleeding into their brain from a hemorrhagic stroke, you will kill them almost instantly.

Because they'll just bleed out.

Exactly.

So you have to prove there's no blood.

How does the CT show that?

On a non -contrast CT scan, acute blood shows up as bright, glaring white.

Contrast dye also shows up as bright white.

If you use contrast, you might look at a bright white spot and not know if it's dye or a fatal hemorrhage.

A clean, non -contrast CT proves there is no active bleeding, which presumes the stroke is ischemic, and opens the door for clot busting protocols.

Alongside the CT, the initial emergency workup includes an ECG.

Why look at the heart when the brain is failing?

Because you are looking for that atrial fibrillation we talked about.

If the heart is quivering instead of pumping, it's throwing clots.

You also check pulse oximetry, and you perform the NIH stroke scale to rapidly quantify the severity of the neurological deficit.

You pull initial labs, too.

CBC, a metabolic profile, a tox screen to ensure the symptoms aren't from cocaine or an overdose, and crucially, PT, PTT, and INR.

Yes, you must know their baseline coagulation status.

If they are already on a high dose of a blood thinner like warfarin, giving them a clot buster could be disastrous.

I see the guidelines mention a lumbar puncture, but only under very specific circumstances.

Yes.

You only perform an LP if you highly suspect a subarachnoid hemorrhage, which classically presents as an explosive, sudden, thunderclap headache.

But the initial CT scan was perfectly normal.

So the CT missed it.

Sometimes tiny bleeds don't show up on a quick CT, but you will find red blood cells floating in the cerebrospinal fluid.

Let's assume the patient survives the acute phase.

The clot is busted, or the bleed is stabilized.

Now we move to the additional diagnostics.

This is the detective work to figure out why the stroke happens so we can prevent the next one.

Right.

You order a transesophageal echocardiogram.

This involves passing an ultrasound probe down the esophagus to look directly at the

Hunting for hidden clots, or structural defects, like a patent form in Oval.

You run a full lipid profile and a hemoglobin A1C to gauge their metabolic and vascular risk.

And what if the patient is unusually young, say a 35 -year -old with no risk factors?

Then you run a massive hypercoagulable workup.

You test for lupus anticoagulant, factor V Leiden, and protein C and S deficiencies to see if they have an autoimmune or genetic mutation that makes their blood pathologically prone to clotting.

Let's pull back and look at the systems level.

As the primary care air traffic controller, what happens from the moment EMS is called for stroke?

How does the interprofessional system engage?

It is a beautifully orchestrated, highly tiered system of care.

EMS recognizes the signs in the field and immediately triggers a stroke code via radio.

They bypass closer, smaller hospitals to direct the ambulance to a designated facility.

The first tier is an acute, stroke -ready hospital.

These are often smaller community hospitals.

They have the critical infrastructure,

a 247 -CT scanner, rapid lab capabilities, and crucially, telemedicine access to remote neurologists.

They can quickly scan the patient, consult the remote expert, and administer the clot -busting drugs within the critical 3 -4 .5 -hour window.

If the patient is highly complex, they move up the chain to primary stroke centers.

These have dedicated stroke units, standardized treatment algorithms, and on -site neurology teams to manage immediate post -stroke complications.

And the top tier is the Comprehensive Stroke Center.

These are the massive, tertiary care facilities.

They have neurosurgical teams ready to operate on ruptured aneurysms.

They have interventional radiologists who can snake a catheter up into the brain and physically pull a clot out of a vessel, a mechanical thrombectomy.

And they have specialized neuro -ICUs.

But despite all this incredible technology, the ultimate role of the primary care provider

The best stroke is the one that never happens.

Your job is aggressive management of hypertension, which is the single most important modifiable risk factor.

It's anti -coagulating patients with atrial fibrillation.

It's controlling diabetes, pushing smoking cessation, and prescribing statins.

You are maintaining the infrastructure so the pipes never burst in the first place.

Which is a perfect segue into our fourth topic, dementia.

Because the health of those vascular pipes over decades directly impacts cognitive function.

We are shifting from acute, sudden brain injury to chronic, insidious cognitive decline.

And vascular issues tie directly into this.

We used to call it multi -infarct dementia, but now we understand it more broadly as vascular dementia.

How does that happen?

If you fail to control a patient's blood pressure, they might not have a massive paralyzing stroke.

Instead, over 20 years, they suffer thousands of tiny silent micro -strokes in the deep white matter of the brain.

The imaging literally shows holes in the brain, right?

Yes, they are called lacunae, which translates to gaps or lakes.

These tiny infarctions destroy the neural pathways required for complex thought and memory.

Vascular dementia is heavily linked to the exact same cardiovascular risk factors we just discussed for stroke.

When an older patient presents with cognitive decline, the immediate fear is always Alzheimer's.

But a good clinician knows the differential diagnosis is vast.

We have to rule out reversible causes.

What are we looking for?

You must approach cognitive decline like a checklist of systems.

Is it metabolic?

A severe hypothyroidism or a profound vitamin B12 deficiency can mimic dementia perfectly.

What else?

Is it infectious?

You have to screen for neurocephalus or HIV encephalopathy.

Is it structural?

An older patient who bumped their head weeks ago might have a slow -bleeding subdural hematoma putting pressure on the cortex.

Are they being exposed to heavy metals or toxic polypharmacy?

You have to rule all of that out before stamping them with an Alzheimer's diagnosis.

Now, the text highlights two absolutely crucial conical reasoning distinctions that can trip up any provider.

Delirium versus dementia and pseudo -dementia versus dementia.

Let's tackle delirium first.

What is the fundamental difference?

It's about the timeline and the trigger.

Dementia is chronic, progressive, and irreversible.

Delirium is an acute, sudden, and heavily fluctuating change in consciousness and cognition.

So it comes and goes.

Exactly.

A patient with dementia might forget their grandchild's name.

A patient with delirium might be wildly hallucinating one hour and deeply lethargic the next.

And delirium always has a precipitating cause.

Always.

It is a brain reacting to a systemic insult.

In older adults, a simple urinary tract infection, a mild pneumonia, a minor electrolyte imbalance, or a newly prescribed sleep medication can trigger profound delirium.

To differentiate this quickly in the clinic or hospital,

we use standardized tools like the confusion assessment method, the CAM.

The CAM looks for acute onset, inattention, disorganized thinking, and an altered level of consciousness.

The key takeaway for the student is this.

You do not treat delirium with dementia drugs.

You must hunt down and treat the underlying precipitant.

Once you cure the UTI, or normalize the sodium levels, the delirium usually clears completely.

Okay.

What about pseudo -dementia?

This sounds like a psychological trick.

It is a fascinating and tragic clinical phenomenon.

In older adults, severe major depression does not always present as sadness or crying.

Often, it manifests as severe cognitive decline, apathy, intense memory loss, and an inability to concentrate.

It looks exactly like dementia.

So how do you tell the difference?

A depressed older man and an Alzheimer's patient might look identical in the exam room.

Again, you look at the timeline and the patient's attitude toward their deficit.

Dementia patients often try to hide their memory loss.

They confabulate or make excuses.

A patient with pseudo -dementia will often highlight their failure, saying, I just can't remember anything.

My brain is gone.

Oh, wow.

That's a subtle but important difference.

Furthermore, if the cognitive problems coincide precisely with the onset of a major depressive episode, perhaps right after the loss of a spouse, you lean toward pseudo -dementia.

Then how do you treat it?

You treat the depression aggressively with SSRIs and therapy.

When the depression lifts, the cognitive function often returns to baseline.

That's great news, right?

It is, however, and this is a critical clinical pearl.

You must remember even after the depression remits, you must monitor that patient closely.

We now know that depression -related cognitive impairment is often a harbinger of actual subsequent dementia years later.

The brain's resilience is fading.

So when working up a new presentation of cognitive decline, the diagnostic labs align perfectly with ruling out those differentials.

You order a CBC, a Comprehensive Metabolic Screen to check kidneys and liver, a TSH to rule out thyroid issues, and B12 and folate levels.

For imaging, a non -contrast CT or an MRI is standard to look for atrophy patterns, rule out that subdural hematoma or a tumor, and check for those vascular lacunae.

If the diagnosis remains murky, specialized PET or SPEC scans can be ordered to visualize the actual metabolic activity of the brain tissue.

Let's discuss interprofessional management.

Families always want a pill to fix it.

What is our pharmacologic approach to Alzheimer's and progressive dementias?

We rely on two main classes of medications.

For mild to moderate dementia, we use cholinesterase inhibitors like dunpeazole, rivastigmine, and galantamine.

Let's explain the mechanism there.

The brain needs a neurotransmitter called acetylcholine for memory and learning.

In Alzheimer's, the cells that produce it die.

Exactly.

We can't bring the cells back.

But cholinesterase is the enzyme that naturally breaks down whatever acetylcholine is left in the synapse.

By inhibiting that enzyme, we allow the remaining acetylcholine to hang around longer, artificially boosting the signal.

And for moderate to severe disease.

We use NMDA receptor antagonists like memantine.

This drug regulates glutamate.

Remember our ALS discussion about glutamate excitotoxicity?

Yeah, frying the circuit board.

Right.

A similar low -level toxicity happens in Alzheimer's.

Memantine blocks the receptor to prevent excess calcium influx, trying to protect the surviving neurons.

But we have to be brutally honest with the families.

These drugs do not alter the underlying pathology.

They do not stop the plaques or tangles.

They do not.

They might just modestly temporarily improve symptoms or slightly delay nursing home placement.

Which means the primary care provider's real job is care coordination and safety planning.

It is the primary focus.

You have to address the realities of a failing brain early.

You bring in occupational therapy to perform driving evaluations.

Taking away the keys is often the hardest conversation.

You have them assess kitchen safety to prevent the patient from leaving the stove on and causing a fire.

You also need to initiate discussions about advanced directives, a living will, and establishing a health care proxy.

And you must do this while the patient still has the legal capacity to participate in those decisions.

You cannot wait until they are entirely lost.

Furthermore, the primary care provider must care for the caregiver.

Yes, caregiver burnout is so real.

The physical and emotional burden of caring for a dementia patient is immense.

You must actively connect a family to resources like the Alzheimer's Association, set up adult daycare programs, and prescribe respite care before the caregiver collapses under the strain.

Having evaluated central cognitive and vascular issues, let's pivot in our fifth topic to a very common, often frustrating patient complaint that straddles the central and peripheral systems – dizziness and vertigo.

It is one of the most common reasons for a primary care visit, and it is notoriously vague.

The very first, absolute most critical clinical step is forcing the patient to define exactly what they mean by dizzy.

You have to categorize their sensation into one of four distinct buckets.

I'll play the patient, let's go through the buckets.

Bucket one.

I feel like the room is spinning around me, or I'm spinning inside the room.

That is vertigo.

It is an illusion of movement.

It implies a direct problem with the vestibular system, the inner ear, or the vestibular nerve pathways in the brain.

Bucket two.

I feel unsteady, like I'm going to fall over, specifically when I stand up and try to walk.

That is disequilibrium.

It's a gait or balance issue, often related to peripheral neuropathy in the feet, Parkinson's disease, or cerebellar problems.

It is a mechanical instability, not a spinning sensation.

Bucket three.

I feel like I'm about to pass out, like my vision is getting dark at the edges.

That is presyncope.

It is a cardiovascular issue.

The brain is momentarily not getting enough blood pressure.

And bucket four.

I just feel fuzzy, floating and out of sorts.

That is lightheadedness.

It is often vague, and is most commonly related to psychiatric causes like anxiety, hyperventilation, or medication side effects.

So if we look at the diagnostics, the pathway you take depends entirely on which bucket the patient is in.

If they describe classic vertigo indicating a vestibular disorder, what are you ordering?

You'd refer for an audiogram to check for associated hearing loss, which could indicate Meniere's disease, or an acoustic neuroma.

You might order an MRI of the brain stem.

And you'd refer to a specialist for vestibular laboratory testing, like electronic stigmography or postureography, which uses eye movements and balance plates to differentiate whether the lesion is in the ear itself or depth in the brain.

But what if they describe presyncope, that feeling of almost passing out?

Then you ignore the ear and look at the heart.

You start with an immediate ECG to look for deadly arrhythmias or heart block.

You might order a Holter monitor for them to wear at home to catch intermittent irregular beats, and an echocardiogram to ensure the heart valves are functioning.

Your lab workup checks for anemia with the CBC, electrolyte imbalances with a metabolic screen, and you rule out syphilis with a rapid plasma ragin, as it can cause weird cardiovascular and neurological overlap.

Let's zero in on the physical exam for the single most common cause of peripheral vertigo.

BPPV, or benign paroxymal positional vertigo, the guidelines highlight the Hall -Pike -Dix positioning maneuver.

Let's explain what is physically happening in the head during BPPV.

Inside your inner ear, you have three semi -circular canals filled with fluid that detect rotational movement.

You also have a central pouch called the utricle, which contains tiny calcium carbonate crystals, we call them canaliths or otoliths.

Okay, crystals in the ear.

In BPPV, trauma, or just age, causes some of these heavy crystals to break loose from the utricle and float into one of the semi -circular canals.

So you have rocks floating in the fluid where they don't belong.

Precisely.

When you move your head, gravity pulls those rocks through the fluid.

The movement of the fluid bends the nerve hairs in the canal, sending a massive false signal to your brain that you are spinning wildly.

So how does the Hall -Pike -Dix maneuver diagnose this?

It is a provocation test.

You have the patients sit on the table, turn their head 45 degrees, and then you rapidly lay them backward so their head hangs off the edge of the table.

That sounds uncomfortable.

It is, but this specific angle aligns the semi -circular canal with gravity.

The rocks plummet down the canal.

And the patient feels incredibly dizzy.

Yes, but more importantly, you are staring at their eyes.

You are looking for a very specific type of nystagmus, a rapid involuntary twitching of the eyeball.

The direction and duration of the twitching tell you exactly which canal has the rocks in it.

If the Hall -Pike -Dix is positive, how does the interprofessional team manage it?

We don't prescribe anti -nausea meds forever, right?

No, medication doesn't fix the anatomical problem.

The first -line treatment is physical therapy, specifically the canalith repositioning procedure, known commonly as the EPLi maneuver.

How does that work?

It is pew geometry and gravity.

The therapist guides the patient through a series of specific slow head movements, holding each position for about 30 seconds.

So you're basically rolling the rocks out.

Exactly.

You are physically rolling those loose crystals out of the semi -circular canal, around the loop, and dropping them back into the utricle where they can be reabsorbed and no longer cause symptoms.

And what is the key counseling point for students to remember after performing the EPLi maneuver?

You must instruct the patient not to lie flat for at least 48 to 72 hours.

They need to sleep propped up on pillows or in a recliner.

If they lie flat too soon, gravity will just pull the crystals right back into the canal, undoing all your work.

You also need to know when to escalate a dizzy patient.

When is dizziness a medical emergency requiring an immediate ER transfer?

You hit the panic button if the dizziness is accompanied by acute focal neurologic symptoms like double vision, slurred speech, or facial droop.

That implies a central stroke in the brain stem or cerebellum.

What else?

You also send them out if they have acute labyrinthitis accompanied by a high fever, which suggests a dangerous bacterial infection of the inner ear that could spread to the brain.

Which brings us to another major medical emergency in our sixth topic.

Guillain -Barre syndrome or GBS?

GBS is terrifying because it is an acute, rapidly evolving bilateral weakness.

It classically ascends, starting as a tingling and weakness in the toes and lower extremities, and rapidly moves up the legs, into the trunk, and toward the arms and face over days or even hours.

And it's almost always triggered by something else, right?

An antecedent infection.

Yes.

The classic triggers are a recent respiratory infection,

a gastrointestinal bug, specifically Campulobacter jejuni, or importantly, the Zika virus.

Let's talk about the mechanism here.

Molecular mimicry.

The immune system basically gets confused.

It's friendly fire.

The patient catches a stomach bug.

Their immune system generates highly specific antibodies to attack the proteins on the surface of the Campulobacter bacteria.

Okay.

Normal immune response so far.

But unfortunately, those bacterial proteins look incredibly similar on a molecular level to the gangliosides that make up the myelin sheath of the patient's own peripheral nerves.

So after the bacteria is dead, the immune system turns around, sees the nerves, and says, there's more of them, and starts attacking the patient's own wiring.

Exactly.

It causes widespread peripheral demyelination.

The electrical signals can no longer travel to the muscles, resulting in profound ascending paralysis.

For diagnostics, the text mandates a lumbar puncture as the most important confirmatory test.

What are you looking for in the cerebrospinal fluid?

You are looking for a phenomenon called albuminocytologic dissociation.

Let's break that word down.

It means a dissociation or a mismatch between the albumin, which is the protein, and the cells, the white blood cells.

In GBS, the intense inflammation causes the blood nerve barrier at the nerve roots to break down.

So stuff leaks in.

Right.

This allows massive amounts of protein to leak into the spinal fluid.

But because it's not an active bacterial infection inside the spinal canal, there is no rush of white blood cells.

So you see a sky -high protein level, but a perfectly normal white blood cell count.

Routine labs might also show an elevated ESR reflecting systemic inflammation,

elevated liver transaminases, and low sodium due to the syndrome of inappropriate antidiuretic hormone,

or SIADH.

GBS is a medical emergency because as that weakness ascends the body, it eventually hits the diaphragm.

How do we know when the weakness threatens the airway and the patient needs to be put on a mechanical ventilator?

You cannot just wait for them to turn blue.

You must anticipate the failure.

The clinical standard is strict monitoring using the 2030 -40 rule for intubation thresholds.

You measure their bedside spirometry every few hours.

What do those numbers represent physically?

You consider elective intubation if they're vital capacity.

The maximum amount of air they can exhale drops below 20 milliliters per kilogram of body weight.

You look at negative inspiratory force, how hard they can suck in air.

If it drops below negative 30 centimeters of water, their diaphragm is failing.

And the 40.

Or if their maximum expiratory pressure, how hard they can push air out to clear a cough drops below 40.

As those numbers approach those thresholds, the interprofessional ICU team must prepare for a secure airway.

Up to 25 % of GBS patients will require mechanical ventilation.

What are the treatments to actually stop the immune system's attack?

We can't just support their breathing.

We have to stop the friendly fire.

We use heavy immunological treatments, either intravenous immunoglobulin, IVIG, or plasma exchange called plasmapheresis.

Plasma exchange literally filters the patient's blood to physically remove the offending confused antibodies.

IV floods the system with healthy donor antibodies that bind to and neutralize the harmful ones.

Both treatments are highly effective at halting the demyelination and reducing the time spent on a ventilator.

Now, here is a crucial point for exams and daily practice.

We use steroids for Bell -Polzi to stop nerve inflammation.

We use steroids for MS.

Are corticosteroids indicated for GBS?

No.

Emphatically no.

The clinical guidelines explicitly state that corticosteroids are not indicated for the treatment of GBS.

Multiple trials have shown they do not speed recovery and may actually cause harm and worsen outcomes in these specific patients.

Aside from the respiratory failure, what else is the ICU team monitoring?

The autonomic nervous system.

GBS doesn't just attack the nerves going to the biceps.

It attacks the autonomic nerves controlling the internal organs.

The system goes completely haywire.

What does that look like clinically?

You will see dramatic, terrifying swings in heart rate.

A patient might require a temporary pacemaker because their heart stops for 10 seconds.

You see massive blood pressure fluctuations from 200 systolic down to 60.

You see severe urinary retention and paralytic ileus in the gut.

Managing GBS requires incredibly tight, multidisciplinary critical care.

Taking a deep breath, let's move from the intensive care unit back to the busy primary care clinic.

Our seventh topic, headaches.

This is a ubiquitous complaint affecting up to 95 % of the general population at some point.

Headaches are the bread and butter of primary care.

And your absolute primary directive as a clinician is separating the benign primary headaches from the dangerous, life -threatening secondary headaches.

Primary headaches being things like migraines, tension -type headaches, and trigeminal autonomic cephalogies, which we commonly call cluster headaches.

Right, and secondary headaches are the ones caused by an underlying pathology, a brain tumor, a bleeding aneurysm, temporal arteritis, or meningitis.

To make this critical distinction quickly, we use the SNOP mnemonic to identify clinical red flags.

Let's spell it out and explore the reasoning.

S is four.

Systemic symptoms.

Does the patient have a fever, unexplained weight loss, a known HIV infection, or a history of cancer?

If they have a headache and a fever, you must consider meningitis.

If they have a headache and a history of breast cancer, you must consider a brain metastasis.

N is four.

Neurological signs.

When you do your physical exam, is there confusion, a change in mental status, new seizures, or asymmetric reflexes?

A benign migraine shouldn't cause a positive Babinski sign.

If you find one, there's a lesion.

On said.

This is crucial.

Was it acute?

Sudden?

A split -second thunderclap headache?

A thunderclap headache reaches maximum blinding intensity within one minute.

What does that actually represent physically?

It strongly suggests a subarachnoid hemorrhage, a ruptured aneurysm, spraying arterial blood over the surface of the brain.

The meninges are highly sensitive to pain, and blood is incredibly irritating.

It feels like getting struck by lightning.

The second O is four.

Is the patient over 50 years old with a new onset of headaches?

Or a progressive headache that's getting worse?

We worry about temporal arteritis or mass lesions in this age group.

New daily headaches in a 60 -year -old are guilty until proven innocent.

And finally, P is four.

Previous headache history.

Is this their first headache ever, or is it fundamentally different in frequency, severity, or clinical features from their usual migraines?

You are looking for a change in the pattern.

Now, if they have any of those SNOE signs, you investigate aggressively.

But looking at the diagnostic guidelines, what if a 25 -year -old woman comes in with a classic, throbbing, one -sided migraine with nausea, and she has zero SNOEP red flags?

What labs or imaging are essential?

None.

Zero.

The guidelines are crystal clear.

No routine labs or imaging are essential for typical primary headaches.

In fact, the Choosing Wisely campaign explicitly advises against unnecessary MRIs or CT scans in these cases.

You are only going to find incidental, benign anomalies that cause immense anxiety, and you are wasting health care dollars.

You only order a CBC, ESR, TSH, or a brain scan if those SNOE signs are present.

In terms of management, we divide pharmacology into abortive stopping a headache that's currently happening and preventive stopping them from forming.

When do you transition a patient to preventive meds?

You initiate preventive therapy, like beta -pluckers, tricyclic antidepressants, or topiramate, if the patient is experiencing more than four debilitating headaches a month, or if their acute attacks are incredibly prolonged and refractory to abortive medicines, you want to give them their life back.

And there are a few important lifespan caveats regarding abortive medications, specifically the tryptans and DHE or dihydroirgotamine.

Yes, you must understand their mechanism.

Tryptans work by causing vasoconstriction.

They shrink the dilated blood vessels in the brain that are causing the throbbing pain.

But they don't just constrict vessels in the brain, right?

Exactly.

They cause systemic vasoconstriction.

Therefore, they pose a serious cardiovascular risk to elderly patients who likely have underlying atherosclerosis in their coronary arteries.

Giving a tryptan to an older adult could trigger a myocardial infarction, a heart attack.

Conservative management is heavily preferred.

And for pregnant women.

Headache control is strictly limited to safe abortive medications only, primarily acetaminophen.

Preventive therapy should be tapered immediately due to teratogenic risks to the fetus.

Okay, let's look closely at one of those dangerous secondary causes of headache in our eighth topic.

Infections of the central nervous system.

We are focusing primarily on meningitis and encephalitis.

What is the fundamental anatomical difference?

Meningitis is the inflammation of the meninges.

The protective membranes surrounding the brain and spinal cord.

The brain tissue itself is largely okay, but the wrapping is infected.

Encephalitis is inflammation of the brain parenchyma itself.

The actual functional tissue of the brain is under attack.

The classic adult triad for bacterial meningitis is fever,

severe headache, and neutral rigidity, a stiff neck.

But the literature notes that this classic triad is actually only seen in roughly 44 % of confirmed cases.

Which means you must maintain a very high index of suspicion.

You cannot wait for the perfect textbook presentation.

Furthermore, if the patient presents with profoundly altered consciousness, behavioral changes, or seizures right away, that points more heavily toward encephalitis because the brain tissue itself is misfiring.

Let's break down the diagnostics.

If you perform a lumbar puncture, how do you interpret the CSF?

This is another classic board exam focus and a critical real -world skill.

Let's compare bacterial meningitis versus viral meningitis like a crime scene investigator.

Let's do it.

First, you look at the opening pressure when you insert the needle.

In a bacterial infection, it's typically highly elevated, often over 180 millimeters of water due to massive purulent swelling.

In a viral infection, it's usually normal or only mildly increased.

Second, you look at the cell count.

A bacterial infection produces a massive violent immune response.

You will see 1 ,000 to 100 ,000 white blood cells, and they will be predominantly neutrophils, the first responders of the immune system.

A viral infection produces a much milder response, usually 10 ,000 to 10 ,000 cells, and they will be predominantly lymphocytes.

And finally, the metabolic fingerprint.

Protein and glucose.

Why do these matter?

Think about what the bacteria are doing.

They are living organisms dividing rapidly in the spinal fluid.

They need energy, so they eat the glucose.

And as they metabolize and die, they leave behind cellular waste, which is protein.

So in bacterial meningitis, you see high protein and incredibly low glucose.

Yes.

Protein shoots up to 100 to 500.

Glucose drops below 40.

And the CSF to serum glucose ratio drops below 0 .4.

In viral meningitis, viruses don't eat glucose in the same way.

So the protein is only mildly elevated, usually 50 to 100.

And the glucose level remains perfectly normal.

That glucose level is your quickest differentiator.

Looking at the overall diagnostic algorithm, you're ordering two sets of blood cultures, a CVC, a serum glucose level to compare to the CSF, and coagulation studies.

But there's a massive imaging caveat you must follow before you ever touch a spinal needle.

Yes.

You must perform a CT scan of the head before the lumbar puncture if you suspect severely increased intracranial pressure.

How do you suspect that clinically?

If the patient has deeply depressed consciousness, new focal neurologic deficits, sluggish pupils, or papillodema swelling of the optic disc seen with an ophthalmoscope.

And why is the CT required first?

What are we afraid of?

Brain herniation.

If the pressure inside the skull is massive due to swelling, and you stick a needle into the lower spine and drain fluid, you create a sudden pressure gradient.

The high pressure in the skull will violently push the brainstem down through the form and magnum, the hole at the base of the skull.

This will instantly crush the respiratory centers and kill the patient.

The CT confirms it's safe to tap.

But here is the absolute most crucial rule for interprofessional management of suspected bacterial meningitis.

What if the CT scanner is delayed?

Give the first dose of intravenous antimicrobials immediately.

You absolutely do not delay antibiotics while waiting for the CT scan or the LP.

The literature is definitive.

Delaying treatment significantly increases morbidity and mortality.

Even if you give the antibiotics, the CSF culture can still yield the offending bacteria an hour or two later, push the drugs to save the brain.

And as always in primary care, prevention is the ultimate goal.

Vaccines are our best, most effective tool.

The interprofessional team must ensure compliance with the Haemophilus influenza type B or Hib vaccine.

We need sequential administration of the pneumococcal vaccines PCV13, followed by PPSU23 for adults over 65.

And the MCV4 meningococcal conjugate vaccine for 11 to 12 year olds with a crucial booster at 16 before they go to college dormitories, plus targeted vaccination for high risk adults.

OK, let's shift gears entirely.

Topic nine, movement disorders and essential tremor.

Movement disorders represent alterations in normal voluntary movement.

The guidelines categorize them beautifully by establishing two main clinical buckets,

insufficient movement, which is hypokinetic, and too much movement, which is hyperkinetic.

Hypokinetic is essentially Parkinson's disease and related Parkinsonian syndromes.

The movement is slow, stiff and difficult to initiate.

Hyperkinetic is broken down further into jerky and non -jerky movements.

Exactly.

Jerky hyperkinetic movements are chaotic and unpredictable.

This includes myoclonus, which are sudden muscle shocks,

chorea, the dancing, flowing movements seen in Huntington's disease,

and domestic disorders like Tourette's.

Non -jerky hyperkinetic movements are more rhythmic or sustained.

This includes dystonia, which are sustained twisting postures and tremors.

For initial diagnostics across all these movement disorders, the focus in primary care is primarily on ruling out reversible, metabolic, or toxic causes.

You are diagnosing Huntington's on day one.

Right.

Your initial battery is a CBC, a comprehensive metabolic profile to check liver and kidney clearance, and a TSH because hyperthyroidism can cause a wicked tremor.

If you suspect an underlying infection or intoxication, you do a highly focused workup, a urinalysis and chest x -ray for hidden infections in the elderly, an ammonia level and liver function tests, and a comprehensive toxicology screen.

You only order a CT scan of the brain if you suspect a structural lesion, like a tumor pressing on the basal ganglia.

Let's focus on one highly specific disorder detailed in this section, essential tremor.

It is incredibly common.

Essential tremor is the most common tremor diathesis worldwide.

It's a benign, chronic condition.

Clinically, it presents as a symmetric, rhythmic action tremor.

It primarily affects the upper extremities, the head causing a yes -yes or no -no bobble, or the vocal cords causing a shaky voice.

The key word there is action tremor.

Yes.

Unlike the resting tremor of Parkinson's, which happens when the hands are quiet in the lap, an essential tremor gets worse when the patient tries to use their hands like drinking from a glass or writing a letter.

The pathophysiology is thought to involve abnormal oscillatory electrical activity in the central nervous system circuits, linking the cerebellum, thalamus, and brainstem.

And importantly, it has a strong autosomal dominant inheritance pattern.

If your parent had it, there's a 50 % chance you will.

So how is it managed?

The pharmacological mainstays are beta blockers, specifically propranolol and anticonvulsants like primidone.

How does a blood pressure medication stop a tremor?

Propranolol works by blocking peripheral beta -2 adrenergic receptors located right in the muscle spindles, dampening the physical -mechanical oscillation of the muscle fiber itself.

Interestingly, many patients self -medicate and report that a small amount of alcohol significantly calms the tremor.

But obviously, as clinicians, we do not recommend chronic alcohol use as a medical therapy.

For severe medically refractory cases that destroy a patient's quality of life, neurosurgery can implant deep brain stimulation, or DBS, devices directly into the thalamus to interrupt the faulty electrical signals.

Speaking of complex central nervous system electrical issues, let's dive into our tenth topic, multiple sclerosis.

MS is a chronic inflammatory autoimmune demyelinating disease of the central nervous system.

The patient's own immune system rogue T -cells cross the blood -brain barrier and attack the myelin sheath, the fatty insulation wrapping the nerve axons.

I always picture it like a freed iPhone charger cable.

If the rubber insulation is chewed away, the electrical signal sparks, shorts out, or fails to reach the phone entirely.

In MS, this causes lesions or plaques in the brain and spinal cord that severely disrupts signal transmission, leading to weakness, blindness, or numbness.

The terminology used to describe the course of the disease is vital for prognosis.

Let's define them.

First is radiographically isolated syndrome, or RIS.

This is when you find MRI lesions typical of MS, perhaps during a scan for a completely unrelated headache, but the patient has absolutely zero clinical symptoms.

They feel fine.

But it's a ticking clock.

About 65 % of patients with RIS will convert to clinical MS within five years.

The next stage is clinically isolated syndrome, CIS.

This is the first strike, an acute or subacute focal neurologic event indicative of demyelination.

For example, a young woman wakes up completely blind in one eye due to optic neuritis.

Up to 90 % of MS patients present initially with a CIS.

From there, the most common trajectory is relapsing remitting MS, or RRMS.

85 % of patients have this at diagnosis.

The disease course is punctuated by acute clinical exacerbations, a sudden flare of symptoms followed by periods of complete or partial clinical remission where the inflammation buys down and the brain attempts to remyelinate the nerves.

But there are also progressive forms, primary progressive, PPMS, and secondary progressive, SPMS.

Primary progressive is brutal.

The patient accumulates neurological disability right from the initial presentation, progressing steadily downward without any clear relapses or periods of remission.

About 10 % of patients face this.

Secondary progressive is thought to be the natural eventual evolution of RRMS.

After a decade or two of relapses and remissions, the compensatory mechanisms fail and the disease shifts to a steadily progressive, worsening course.

To confirm this diagnosis, we rely heavily on imaging.

The goal standard is an MRI of the brain and spine with gadolinium contrast following the consortium of multiple sclerosis centers protocol, by gadolinium.

Gadolinium is a large contrast molecule.

Normally, the blood -brain barrier keeps it out of the brain tissue.

But during an active MS flare, the inflammation breaks down that barrier.

The gadolinium leaks into the brain precisely where the active demyelination is happening, causing those fresh lesions to enhance or light up bright white on the MRI.

You're looking for plaques disseminated in both space, different areas of the brain, and time, some old inactive plaques and some newly enhancing plaques.

And if the MRI is inconclusive, you perform a lumbar puncture.

What is the signature of MS in the spinal fluid?

You are looking for oligoclonal bands, specifically in tube number four of the CSF draw.

Explain what an oligoclonal band actually is.

They are concentrated bands of IgG immunoglobulins antibodies.

Finding them in the CSF, but not in the patient's blood serum, proves that populations of rogue plasma cells have physically relocated inside the central nervous system and are actively manufacturing antibodies against the brain.

It is proof of local intraciculal inflammation.

The interprofessional management of MS is arguably one of the most sprawling and complex in all of primary care.

It requires a massive team effort just for symptomatic care.

Absolutely.

The disease hits every system.

For ataxia and mobility loss, you need physical therapy and comprehensive home safety evaluations by an occupational therapist.

For severe bladder urgency and incontinence, you need urology consults and anti -cholinergic medications.

For bowel dysfunction, dieticians to manage fiber and fluids.

For cognitive dysfunction, a detailed neuropsychological evaluation to establish a baseline.

And depression affects over 50 % of MS patients, due to both the psychological burden of the disease and actual inflammatory lesions in the emotional centers of the brain.

You must aggressively manage this with ASSRIs and psychiatric counseling.

But beyond just managing symptoms, we have disease modifying therapies, or DMTs.

The clinical goal is to start these as early as possible, usually right after a clinically isolated syndrome.

We want to lock the immune system down before it does permanent damage.

Exactly.

DMTs aim to decrease the annualized relapse rate, decrease the formation of new MRI lesions, and fundamentally slow disability progression.

The classic injectable platform therapies include interferons and glateramer acetate.

What's the clinical difference between them regarding side effects?

With interferons, they are highly effective but have a heavy side effect profile.

You must continuously monitor liver function tests for hepatotoxicity and watch incredibly carefully for severe depression and suicidal ideation, which is a known black box warning.

Glateramer acetate operates differently.

It mimics myelin protein to distract the immune system, and crucially, it does not carry those severe liver or depression concerns.

And what do you do when the patient has an acute exacerbation, a sudden terrifying worsening of symptoms?

You hit the inflammation as hard and fast as possible.

You use short, powerful courses of high dose corticosteroids like intravenous methylprednis or alternatively you can use ACTH injections.

How does ACTH work?

Adrenocorticotropic hormone.

It doesn't just stimulate the adrenal glands to make natural cortisol.

It also directly binds to melanocortin receptors in the brain, down regulating the inflammatory cascade through a completely independent pathway from standard steroids.

The primary care role here is to act as the conductor of this collaborative care team orchestra.

But also you must remember that MS patients have an intrinsically flawed immune system, meaning they are at a statistically much higher risk for developing other comorbid autoimmune diseases like autoimmune thyroiditis, type 1 diabetes, and rheumatoid arthritis.

You cannot develop tunnel vision on the MS.

You have to treat the whole patient.

Let's transition to another major neurodegenerative disease in our eleventh topic, Parkinson disease.

PA is a slowly progressive neurodegenerative disease.

Its prevalence shoots up rapidly after age 65.

While MS destroys myelin, Parkinson's destroys the actual neurons in a specific area of the brainstem called the substantia nigra, severely depleting the brain supply of dopamine.

Dopamine is the critical neurotransmitter for smooth coordinated purposeful movement.

When it's gone, you see the four cardinal features of PD.

We touched on this earlier, but let's define them formally.

Feature one,

an asymmetric resting tremor.

This is classically described as a pill rolling tremor in the fingers.

It happens when the hand is completely at rest and often temporarily goes away when the patient reaches for something.

Feature two, bradykinesia.

This is a generalized, profound slowness of movement.

It takes them incredibly long to button a shirt, and their facial expressions become blunted, leading to a masked face appearance.

Feature three, rigidity.

This is a severe stiffness in the limbs, often described as cogwheel rigidity when you passively bend their arm.

And feature four, postural instability.

The loss of automatic balance reflexes, leading to a shuffling gait and frequent dangerous falls.

The interprofessional management of Parkinson's is highly individualized.

As the guidelines emphasize, while we have powerful drugs like livadopa to replace the missing dopamine and improve symptoms,

no drug currently exists that actually stops or slows the underlying neuronal death.

Therefore, the ultimate role of care is maximizing daily function and independence for as long as possible, and that requires a heavy reliance on the allied health team.

Explain the role of physical therapy here, because it's not just about building muscle.

It's about neuromodulation.

Physical therapists teach PD patients specific, exaggerated movement strategies.

Because the automatic movement pathways are broken, patients have to use conscious cortical thought to take large steps and swing their arms.

It is exhausting, but it prevents falls.

Occupational therapy is brought in for adaptive equipment -weighted utensils to counteract the tremor, and home modifications.

And crucially, a psychiatric referral is heavily recommended.

The psychological toll of Parkinson's is immense.

Depression is incredibly common, not just as a reaction to the diagnosis, but as a primary neurochemical result of the disease spreading to the brain's mood centers.

Cognitive deficits and eventual Parkinson's dementia also develop in late stages, so establishing baseline neuropsychological documentation early on is vital.

Health promotion is a massive part of the primary care role here.

You are not just managing the medical chart.

You are connecting patients and their exhausted families to advocacy organizations like the American Parkinson Disease Association, the National Parkinson Foundation, and the Michael J.

Fox Foundation.

These groups provide immense practical support, exercise classes, and research trial access that a 15 -minute clinic visit simply cannot offer.

Moving from chronic, slow neurodegeneration to sudden, acute neurological electrical storms, we arrive at our twelfth topic, seizures and epilepsy.

Epilepsy is defined clinically as a brain disorder, characterized by an enduring predisposition to generate recurrent, unprovoked seizures.

The brain's electrical grid suddenly shorts out and fires synchronously.

Can you clarify the International League Against Epilepsy, the ILAE classification framework?

Because the old terms like Gras Mal and Petit Mal are outdated.

Broadly, seizures are now classified into two main types based on how and where they begin in the brain's electrical network.

First, we have focal seizures.

Which means they start in one specific location.

Yes, they originate in neuronal networks limited to just one cerebral hemisphere.

They can occur without impaired consciousness.

The patient is fully awake, but their arm might be uncontrollably jerking.

Or they might experience a strange smell or visual aura.

Or a focal seizure can occur with impaired consciousness if the aberrant electrical activity spreads to areas controlling awareness.

And the second type.

Generalized seizures.

These involve abnormal electrical networks engaging across both hemispheres of the brain simultaneously right from the very start.

This includes absent seizures, where a child might just stare blankly into space for 10 seconds, and the classic generalized tonic -clonic seizures, which involve a sudden loss of consciousness, body stiffening, and violent rhythmic convulsions.

The absolute most critical part of this chapter for any clinical student is the acute management of status epilepticus, or SE.

This is a massive, life -threatening medical emergency.

SE is defined clinically as a continuous seizure lasting five minutes or more, or two consecutive seizures occurring without the patient fully regaining baseline consciousness in between them.

Why is five minutes the magic number?

Because historically we waited 30 minutes.

But we now know that if a seizure goes beyond five minutes, the brain's normal inhibitory mechanisms have definitively failed, and it is highly unlikely to stop on its own.

If the electrical storm goes beyond 30 minutes, the brain cells begin to literally burn themselves out.

You start seeing permanent, irreversible, excitotoxic brain damage,

severe hypothermia, metabolic athidosis, and deadly cardiac arrhythmias.

Let's walk step -by -step through the precise timeline table for treating status epilepticus in the ER.

Minute zero to five.

This is the stabilization phase.

You assess airway, breathing, and circulation.

You give supplemental oxygen.

You place them on continuous ECG monitoring.

And crucially, you get a rapid finger stick blood glucose.

Why glucose first?

Because severe hypoglycemia can cause a refractory seizure.

If the glucose is less than 60 mg per deciliter, you push 50 ml of D50W intravenous dextrose to reverse it.

However, if the patient is an adult with suspected alcohol use disorder or malnourishment, you must push IV thiamine before you give the sugar.

Why the thiamine first?

Pushing pure glucose into a thiamine -deficient brain will instantly trigger Bernike's encephalopathy, causing devastating permanent brain damage.

Thiamine is the cofactor needed to metabolize that glucose safely.

Okay, the sugar is fine, but they are still seizing.

Minute five to twenty.

This is the first -line therapy window.

Benzodiazepines.

This is an evidence level A recommendation.

How do benzos physically stop a seizure?

They are allosteric modulators of the GABA receptor.

GABA is the brain's primary inhibitory neurotransmitter.

It's the chemical stop sign.

Benzos enhance the power of GABA, flooding the brain with inhibitory signals to forcefully shut down the runaway electrical storm.

You administer intramuscular mitazolam, intravenous lorisberos, or intravenous diazepam.

But what if the seizure fights through the benzos?

Minute twenty to thirty.

Second -line therapy.

You must load them with a heavy intravenous antiepileptic drug.

The guidelines list options.

For a phosphonutriene, IV -avalproic acid or IV -levotriacetam.

Phosphonutriene works by blocking sodium channels, physically preventing the neurons from resetting and firing again.

There is no single universally preferred drug here.

You choose based on hospital protocol, availability, and patient comorbidities.

And if they are still seizing past forty to sixty minutes?

You have entered refractory status epilepticus.

The mortality rate here is exceptionally high.

You have to immediately intubate the patient to protect their airway and induce a pharmacological coma using general anesthesia.

You use continuous, heavy intravenous infusions of propofol, midazolam, or thiopental.

This must be guided by continuous EEG monitoring of the brain waves to ensure the brain's electrical activity has been completely and totally suppressed into a burst suppression pattern.

Beyond acute medications, the text mentions fascinating surgical options for chronic, medically refractory epilepsy.

One that stands out is the corpus callosotomy.

It is an extreme but incredibly effective palliative surgery.

They do not remove any brain tissue.

Instead, the neurosurgeon physically severs the corpus callosum.

The massive bundle of nerve fibers connecting the right and left hemispheres of the brain.

To stop the electrical fire from spreading.

Exactly.

It prevents a focal seizure in one hemisphere from generalizing across the whole brain.

It is highly effective for patients who suffer from devastating drop attacks or atonic seizures, where they lose all muscle tone instantly and crash to the floor, sustaining severe facial and head traumas.

Okay, we have two sections left.

Let's look at a condition often described as the most agonizing pain known to medicine.

Topic 13,

trigeminal neuralgia.

This is characterized by sudden, severe, unilateral, electric shock -like facial pain occurring strictly in the sensory distribution of cranial nerve V, the trigeminal nerve.

The pain is so excruciating, it has historically been called the suicide disease.

The pathophysiology usually involves physical compression.

A torturous looping blood vessel, often the superior cerebellar artery pulsates against the root entry zone of the trigeminal nerve near the brainstem.

Over time, that constant physical beating wears away the myelin sheath, causing the nerve to become hyper -excitable and fire massive pain signals at the slightest touch.

Diagnostics are primarily clinical, based on the patient's description, but you must order an MRI or MRA.

Yes.

You aren't looking for the vascular loop necessarily.

You are looking to rule out secondary,

dangerous causes of compression.

You want to ensure there isn't a meningioma tumor crushing the nerve, or a multiple sclerosis demyelinating plaque sitting right on the nerve root.

For interprofessional management, ordinary painkillers like ibuprofen or even heavy opioids do practically nothing for this neuropathic pain.

The first -line pharmacologic therapy is anticonvulsants, specifically carbamazepine, or oxcarbazepine.

They quiet down the hyper -excitable nerve.

But there's a massive tutoring point here regarding monitoring.

Carbamazepine requires incredibly strict laboratory monitoring by the primary care provider.

You must check a CBC, serum sodium levels, and liver function tests periodically.

It carries severe, black -box risks of hematologic changes like a granulocytosis, a total wipeout of white blood cells, severe liver toxicity, and hyponutremia due to SIADH.

If they fail three different medications, you refer them to a neurosurgeon for an assessment for microvascular decompression, where the surgeon physically places a tiny Teflon sponge between the beating artery and the nerve root.

But I want to highlight the primary care support role here while they are waiting for that surgery or if they aren't surgical candidates.

The text notes the unique, devastating challenges of oral intake.

The trigger zones for the pain are often on the lips, gums, or cheek.

The pain can be triggered by the slightest tactile stimulus of breeze, chewing food, or bristles touching the teeth.

The fear of pain is so severe that patients simply stop eating, drinking, and brushing their teeth.

Which leads to massive weight loss, dehydration, and horrific dental decay.

The primary care provider must intervene creatively.

You advise patients to use long straws for liquid, high -calorie nutrition, bypassing the lips entirely.

You suggest they use oral water flossers on a low setting instead of abrasive toothbrushes.

These incredibly small, practical adaptations can vastly improve their life and prevent severe secondary malnutrition while the medical therapies take effect.

Finally, we reach our 14th and final topic,

intracranial tumors.

This encompasses both primary brain tumors that originate in the brain tissue and metastases that spread from systemic cancers like lung or breast cancer.

Let's review the WHO classification table for primary tumors because understanding the cell of origin dictates the prognosis.

You have astrocytomas, which arise from star -shaped glial cells.

These range from a slow -growing, benign -grade pellicitic astrocytoma, often seen in children, all the way up to a highly malignant, rapidly fatal, grade the fourth, glioblastoma.

You also have oligodendrogliomas, ependymomas, lining the ventricles, and meningiomas.

Meningiomas account for about 37 % of primary tumors.

They're usually benign and grow slowly from the meningial wrapping, pushing on the brain rather than invading it.

And then you have primary CNS lymphomas, an aggressive cancer of the lymphocytes within the brain, often seen in immunocompromised patients.

The initial diagnostics box for a suspected tumor recommends a non -contrast CT of the head first, if they present to the ER,

followed definitively by a brain MRI with and without gadolinium contrast.

If you suspect the brain tumor is actually metastatic disease, which is vastly more common than a primary brain tumor, you expand your search.

You order a CT of the chest, abdomen, and pelvis, and potentially a full -body PE scan to hunt down the primary source of the cancer.

In terms of interprofessional management, while the neurosurgeons and oncologists plan the attack, the primary care team manages the devastating support of care.

A major issue is Vezergenic edema.

This is the swelling of the healthy brain tissue immediately surrounding the tumor mass.

The tumor's leaky blood vessels cause fluid to pour into the tight space of the skull,

causing massive pressure, headaches, and focal deficits.

To manage this edema rapidly, we use heavy corticosteroids.

Dexamethasone is the undisputed rug of choice in neuro -oncology.

Why?

Because compared to prednisone, dexamethasone has very low mineralocorticoid activity.

This means it causes significantly less systemic salt and water retention, which is exactly what you want when trying to dry out a swollen brain.

It also has a dose in taper fast to avoid steroid -induced diabetes, myopathy, and psychosis.

There is a major specific caveat here, though, regarding steroids and diagnostic biopsies, a trap you do not want to fall into.

Yes.

You must aggressively avoid giving steroids before a neurosurgical biopsy if you suspect a primary CNS lymphoma.

Why?

Because corticosteroids are inherently lymphocytotoxic.

They induce rapid apoptosis, or cell death, in lymphocytes.

If you give high dose dexamethasone to a patient with a CNS lymphoma, the tumor will literally melt away temporarily.

Which sounds good until the surgeon goes in.

Exactly.

The surgeon performs the biopsy, but the tissue is completely necrotic and altered.

The pathologist cannot make a definitive diagnosis, the patient undergoes brain surgery for nothing, and the tumor will aggressively recur weeks later once the steroids are stopped.

Symptom control for brain tumor patients requires a deeply multifaceted approach from the whole team.

Profound fatigue is universal, and can sometimes be treated with careful use of CNS stimulants, like methylphenidate.

Seizures occur in up to 80 % of patients with certain tumors and require prophylactic anticonvulsants.

Depression is massive and requires SSRIs and intense psychological support.

But there's a key pharmacological warning here.

Avoid bupropion for depression in these patients.

Bupropion is an excellent antidepressant, but it carries a known side effect of lowering the seizure threshold.

Brain tumor patients are already at an exceptionally high risk for seizures due to the mass irritating the cortex.

Giving them bupropion could easily push them into status epilepticus.

As we look at the long -term reality of lifespan and survivorship, chronologic age is considered alongside the patient's Karnafsky performance score, a metric of their functional independence to determine if aggressive treatments like craniotomy, radiation, and chemotherapy are viable, or if palliative hospice care is the more humane route.

And as treatments do succeed, primary care must introduce comprehensive survivorship care plans to help patients transition from active oncology treatment back to post -treatment life, managing the permanent late effects of whole brain radiation and neurotoxic chemo.

It is about maintaining that continuum of care from the very first headache complaint all the way through treatment and into survivorship or dignified end -of -life care.

Okay, take a breath.

We have covered an absolutely incredible breadth of neurological knowledge today.

We've gone from identifying the nuanced, life -saving difference between a bell palsy and a stroke on a physical exam, to managing the critical minute -by -minute timeline of status epilepticus.

We've unpacked the molecular mechanisms of Guillain -Barré, the SNOP mnemonic for dangerous headaches, and the intricate crime scene -like CSF interpretations from meningitis.

If there is one final provocative thought I want to leave with you, the student listener, it is this.

As a primary care provider, you are the ultimate diagnostician.

A patient's life -altering diagnosis of multiple sclerosis or Parkinson's or a glioblastoma almost never starts in a neurologist's office.

It starts with a single, subtle, easily dismissed complaint in your primary care exam room.

A dizzy spell, a twitch, a headache, a slight change in memory.

How will you hone your active listening and your clinical reasoning to catch the clues that others might dismiss as just stress or anxiety or getting old?

The diagnostic muddy waters are deep, and they are ever -present.

But if you understand the path of physiology, if you trust your physical exam, and if you utilize your interprofessional team, you have the framework to navigate them successfully and save lives.

Thank you for joining us for this incredibly expensive deep dive into the nervous system.

Thank you from the Last Minute Lecture team.

Go review your notes, crush those upcoming boards, and take excellent care of your patients.